{"schema_version":"secwatch.filing_event.v1","accession":"0001601485-25-000046","form_type":"8-K","ticker":"ELTX","cik":"0001601485","company_name":"Elicio Therapeutics, Inc.","filed_at":"2025-03-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.153185+00:00","generated_at":"2026-05-24T01:51:02.521931+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"low","headline":"Elicio Therapeutics reports year-end 2024 results; press release text unreadable","bullets":["Filing announces financial results for year ended Dec 31, 2024 and corporate updates.","Attached press release (Exhibit 99.1) contains extensive encoding corruption; specific figures not extractable.","No legible quantitative guidance or material non-financial updates identified in the exhibit.","Management change or other items not mentioned; only operational update alluded to."],"urls":{"canonical":"https://secwatch.observer/filing/0001601485-25-000046","json":"https://secwatch.observer/filing/0001601485-25-000046.json","markdown":"https://secwatch.observer/filing/0001601485-25-000046.md","text":"https://secwatch.observer/filing/0001601485-25-000046.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1601485/000160148525000046/0001601485-25-000046-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1601485/000160148525000046/angn-20250331.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T01:51:02.521931+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}